If you have an elevated PSA (Prostate Specific Antigen) after a radical retropubic prostatectomy (RRP), you may be eligible to participate in one of these research studies.
Multi-Site, Collection of Anonymized Biological Specimens and Phenotypic Data from a Large Cohort of Subjects for Inclusion in a Repository ad Use in Genomic (from DNA and RNA), Serologic and Metabolic (from Serum) and Proteomic (from Protein) research studies (Pro00005300).
Research Locations:
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
410-825-6310
Contact Debi Robertson, drobertson@cua.md or 443.471.5873
Glen Burnie/Landmark
806 Landmark Drive, Suite 118
Glen Burnie, MD 21061
410-760-9400
Contact Virginia Michaels, vmichaels@cua.md or 443.471.5753
GBMC
Physicians Pavilion North
6535 North Charles St., Suite 625
Baltimore, MD 21204
410-825-5454
Contact Valerie Nevins, vnevins@cua.md or 443.471.5740
Franklin Square/White Marsh
6830 Hospital Drive, Suite 204
Baltimore, MD 21237
410-391-6131
Contact Angela Somers, asomers@cua.md or 443.471.5829
For additional information go to www.bioserve.com
A Multicenter Clinical Study of the Sonablate (Sonablate for the Treatment of locally Recurrent Prostate Cancer with HIFU (STAR Trial).
Research Locations:
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
410-825-6310
Contact Debi Robertson, drobertson@cua.md or 443.471.5873
For additional information go to www.prostatecancerrecurrenttrial.org
A Randomized, Controlled, Open-Label Trial of Degarelix Intermittent Therapy vs. Continuous Androgen Deprivation Therapy with Leuprolide or Degarelix in Patients with Carcinoma of the Prostate with Biochemical Failure after Localized Therapy.
Research Locations:
GBMC
Physicians Pavilion North
6535 North Charles St., Suite 625
Baltimore, MD 21204
410-825-5454
Contact Valerie Nevins, vnevins@cua.md or 443.471.5740
Franklin Square/White Marsh
6830 Hospital Drive, Suite 204
Baltimore, MD 21237
410-391-6131
Contact Angela Somers, asomers@cua.md or 443.471.5829
For additional information go to www.myclinicaltrial.com/PSA
A randomized, controlled, open-label trial of Degarelix intermittent therapy vs. continuous androgen deprivation therapy with Leuprolide or Degarelix in patients with carcinoma of the prostate with biochemical failure after localized therapy.
For additional information go to: www.ferring.com
Research Locations:
Towson, MD
Physicians Pavilion North
6535 North Charles St., Suite 625
Baltimore, MD 21204
Contact Heather Thomas, hthomas@cua.md or 410-825-5454
Glen Burnie, MD
806 Landmark Dr., Suite 118
Glen Burnie, MD 21061
Contact Virginia Michaels, vmichaels@cua.md or 410-760-9400
Franklin Square
6830 Hospital Dr., Suite 204
Baltimore, MD 21237
Contact Angela Somers, asomers@cua.md or 410-391-6131 x1212
|
 |
|
« Current Clinical Trials
|
|
|
|
Erectile Dysfunction (ED)
|
|
|
|
Enlarged Prostate: (Benign Prostatic Hyperplasia/BPH)
|
|
|
|
Peyronies
|
|
|
|
Kidney Stones
|
|
|
|
Bladder Cancer
|
|
|
|
Prostate Cancer
|
|
|
|
Overactive Bladder
|
|